A Clinical Study Evaluating the Safety and Efficacy of SKG0106 in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Recruiting now · Phase 1

Conditions studied: Neovascular Age-related Macular Degeneration

In brief

This is a clinical study to evaluate the safety, preliminary efficacy, immunogenicity of SKG0106 in subjects with nAMD.

Key facts

Study ID
NCT06213038
Run by
Youxin Chen
People needed
12
Starts
2023-05-05
Expected to finish
2025-05-30
Last updated by the study team
2025-01-08

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.